Department of Physics, Faculty of Engineering and Physical Science, University of Surrey, Surrey GU2 7JP, UK.
Phys Med Biol. 2013 Feb 7;58(3):497-511. doi: 10.1088/0031-9155/58/3/497. Epub 2013 Jan 10.
It is essential that quality control (QC) techniques are developed to keep pace with modern high dose rate (HDR) brachytherapy. Current QC methods may be insufficient to fully assure the accuracy of 3D-optimized dose delivery. This work presents an evaluation of Gafchromic EBT3 film, with multi-channel analysis, in HDR dose environments for advanced QC and commissioning. 'Film-array in water' and 'three-channel Solid Water block' purpose-designed phantoms are utilized. Dose and dose-rate dependency and practical film usage has been evaluated. EBT3 measurements of dose with radial distance from a HDR source are compared to Monte Carlo data. Semi-3D dose distributions around clinical HDR applicators are compared to treatment plans. The measurement of delivery accuracy for inverse-planned pseudo-clinical test cases, with correct delivery and simulated treatment errors, has also been investigated. Local gamma criteria of 3%, 3 mm is recommended with passing rates of at least 96% typically achieved. The system is sensitive to simulated errors in HDR delivery, with significant reductions of passing rate. It has been demonstrated that EBT3 Gafchromic film, in combination with multi-channel analysis, is appropriate for applicator, treatment unit and planning system commissioning measurements as well as practical routine QC to confirm agreement of planned and delivered complex HDR brachytherapy dose distributions.
有必要开发质量控制 (QC) 技术,以跟上现代高剂量率 (HDR) 近距离治疗的步伐。目前的 QC 方法可能不足以完全确保 3D 优化剂量输送的准确性。本工作评估了 Gafchromic EBT3 胶片,结合多通道分析,用于 HDR 剂量环境中的高级 QC 和调试。使用了专门设计的“水中胶片阵列”和“三通道固体水块” phantom。评估了剂量和剂量率依赖性以及实际胶片使用情况。从 HDR 源的径向距离测量 EBT3 的剂量,并将其与蒙特卡罗数据进行比较。将临床 HDR 施源器周围的半 3D 剂量分布与治疗计划进行比较。还研究了对逆计划假临床测试用例的输送准确性的测量,这些测试用例具有正确的输送和模拟的治疗误差。建议采用 3%、3mm 的局部伽马标准,通过率通常至少达到 96%。该系统对 HDR 输送中的模拟误差很敏感,通过率显著降低。已经证明,EBT3 Gafchromic 胶片与多通道分析相结合,适用于施源器、治疗单元和计划系统的调试测量,以及实际常规 QC,以确认计划和输送的复杂 HDR 近距离治疗剂量分布的一致性。